We are live on ! Find out more
EFTR

eFFECTOR Therapeutics, Inc. Common Stock
EFTR

Delisted

EFTR was delisted on the 2nd of July, 2024.

Back to rankings

43 hedge funds and large institutions have $80.3M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+43
Holders Change %
–
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
+$9.82M
2
LA
Linden Advisors
New York
+$8.93M
3
MI
MMCAP International
Cayman Islands
+$4.91M
4
PAMP
Polar Asset Management Partners
Ontario, Canada
+$4.91M
5
PC
Periscope Capital
Ontario, Canada
+$4.51M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Atalaya Capital Management
New York
$952K +$960K +3,912 New
EAM
27
Exos Asset Management
New York
$641K +$646K +2,632 New
BI
28
Bulldog Investors
New Jersey
$487K +$491K +2,000 New
PI
29
PEAK6 Investments
Illinois
$487K +$491K +2,000 New
Marshall Wace
30
Marshall Wace
United Kingdom
$486K +$491K +1,999 New
WRBC
31
W.R. Berkley Corp
Connecticut
$479K +$488K +1,988 New
Bank of America
32
Bank of America
North Carolina
$261K +$266K +1,083 New
Jane Street
33
Jane Street
New York
$245K +$248K +1,012 New
RCM
34
Rivernorth Capital Management
Florida
$244K +$245K +1,000 New
HighTower Advisors
35
HighTower Advisors
Illinois
$240K +$246K +1,001 New
FTUS
36
Flow Traders U.S.
New York
$225K +$229K +934 New
RA
37
Ramius Advisors
New York
$168K +$169K +688 New
NAM
38
Nexpoint Asset Management
Texas
$142K +$143K +584 New
AC
39
Aristeia Capital
Connecticut
$138K +$139K +568 New
ACA
40
Arena Capital Advisors
California
$137K +$138K +562 New
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$134K +$137K +558 New
Morgan Stanley
42
Morgan Stanley
New York
$5K +$4.91K +20 New
WAM
43
Wolverine Asset Management
Illinois
$5K +$5.89K +24 New
1
2

EFTR Hedge Fund Activity: Q1 2021 in Review

43 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Common Stock (EFTR) for Q1 2021, worth a combined $80.3M.

Buyers outnumbered sellers: 43 funds opened new EFTR positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Empyrean Capital Partners, opening a new position worth an estimated $9.82M.

  • 43 institutional investors held eFFECTOR Therapeutics, Inc. Common Stock (EFTR) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $80.3M of eFFECTOR Therapeutics, Inc. Common Stock stock for Q1 2021.
  • 43 funds opened new eFFECTOR Therapeutics, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +43 holders.
  • The largest eFFECTOR Therapeutics, Inc. Common Stock buyer in Q1 2021 was Empyrean Capital Partners, an estimated $9.82M added.

Based on aggregated 13F filings for Q1 2021.